Nayson Fernandes, MD
Neurology · Pasadena
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Fernandes’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Illinois 036168753Licensed Physician And Surgeon · since 2024 · expires 2026-07-31Matched by name, not licence number; check the name before relying on it.InactiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Drugs they prescribed that Part D paid
$7,688
Pharmacies billed $7,688 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 75) in 2024. At or below the middle of the specialty; the typical student in an organized health care education/training program clinician is at 0%.
68 generic and fewer than 11 brand-name prescriptions · $7,688 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Levetiracetam | 11 | $301 | $27 |
| Duloxetine | 11 | $120 | $11 |
| Amitriptyline | 11 | $59 | $5 |
Year by year
| 2024 | 75 | 17 | 0% (0) | None | $7,688 |
| 2023 | 108 | 25 | 0% (0) | None | $14,368 |
| 2022 | 73 | 21 | 0% (0) | None | $7,134 |
| 2021 | 75 | 26 | 0% (0) | None | $5,506 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Oxcarbazepine | 22 | $2,755 | $125 |
| Levetiracetam | 17 | $968 | $57 |
Money from drug and device companies
$21 in 2025
| 2025 | 1 | 1 | None | $21 |
| 2024 | 1 | 1 | None | $75 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Sensight | $21 | 1 payment
|
See the published payment
| Medtronic | Meals · 2025-03-24 | Sensight | $21 |
See earlier years (2024)
2024: $75
| Amgen | Uplizna | $75 | 1 payment
|
Professional record
- NPI
- 1649809484
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 912 S Wood St Rm 174, Chicago, IL, 60612
- NPI first listed
- 2020-04-03
- NPI last updated
- 2026-06-02
- NPI record certified
- 2026-06-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 550 1st Ave, New York, NY, 10016